Your browser doesn't support javascript.
loading
Non-alcoholic fatty liver disease: A patient guideline.
Francque, Sven M; Marchesini, Giulio; Kautz, Achim; Walmsley, Martine; Dorner, Rebecca; Lazarus, Jeffrey V; Zelber-Sagi, Shira; Hallsworth, Kate; Busetto, Luca; Frühbeck, Gema; Dicker, Dror; Woodward, Euan; Korenjak, Marko; Willemse, José; Koek, Gerardus H; Vinker, Shlomo; Ungan, Mehmet; Mendive, Juan M; Lionis, Christos.
Afiliação
  • Francque SM; Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium.
  • Marchesini G; Laboratory of Experimental Medicine and Paediatrics (LEMP), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Kautz A; InflaMed Centre of Excellence, University of Antwerp, Antwerp, Belgium.
  • Walmsley M; Translational Sciences in Inflammation and Immunology, University of Antwerp, Antwerp, Belgium.
  • Dorner R; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy.
  • Lazarus JV; Department of Medical and Surgical Sciences, "Alma Mater" University, Bologna, Italy.
  • Zelber-Sagi S; Kautz gUG, Cologne, Germany.
  • Hallsworth K; PSC Support, Oxford, United Kingdom.
  • Busetto L; Kautz gUG, Cologne, Germany.
  • Frühbeck G; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Spain.
  • Dicker D; School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.
  • Woodward E; Department of Gastroenterology and Hepatology, The Tel-Aviv Medical Center, Tel-Aviv, Israel.
  • Korenjak M; Newcastle NIHR Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
  • Willemse J; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Koek GH; Department of Medicine, University of Padova, Italy.
  • Vinker S; European Association for the Study of Obesity.
  • Ungan M; Department of Endocrinology & Nutrition, University of Navarra Clinic, IdiSNA, CIBEROBN, Pamplona, Spain.
  • Mendive JM; European Association for the Study of Obesity.
  • Lionis C; Department of Internal Medicine, Rabin Medical Center Hasharon Hospital, Tikva, Israel.
JHEP Rep ; 3(5): 100322, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34693236
ABSTRACT
This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawareness. Furthermore, many aspects of the disease are still to be unravelled, which has an important impact on the information that is given (or not) to patients. Its management requires a close interaction between patients and their many healthcare providers. It is important for patients to develop a full understanding of NAFLD in order to enable them to take an active role in their disease management. This guide summarises the current knowledge relevant to NAFLD and its management. It has been developed by patients, patient representatives, clinicians and scientists and is based on current scientific recommendations, intended to support patients in making informed decisions.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article